当前位置：
X-MOL 学术
›
Lancet Diabetes Endocrinol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Bone mineral density as a surrogate endpoint for fracture risk reduction in clinical trials of osteoporosis therapies: an update on SABRE
The Lancet Diabetes & Endocrinology ( IF 44.0 ) Pub Date : 2024-04-24 , DOI: 10.1016/s2213-8587(24)00092-5 Dennis M Black 1 , Austin R Thompson 1 , Richard Eastell 2 , Mary L Bouxsein 3
中文翻译：
骨质疏松症治疗临床试验中骨矿物质密度作为降低骨折风险的替代终点：SABRE 更新
更新日期：2024-04-24
The Lancet Diabetes & Endocrinology ( IF 44.0 ) Pub Date : 2024-04-24 , DOI: 10.1016/s2213-8587(24)00092-5 Dennis M Black 1 , Austin R Thompson 1 , Richard Eastell 2 , Mary L Bouxsein 3
Affiliation
中文翻译：
骨质疏松症治疗临床试验中骨矿物质密度作为降低骨折风险的替代终点：SABRE 更新
京公网安备 11010802027423号